Thymalin is a bioregulatory peptide complex originally isolated from the thymus gland. In clinical data and longevity research (notably the work of Vladimir Khavinson), it is classified as a “cytomax”—a group of peptides that act as epigenetic modulators to restore organ function.

Below is a breakdown of the reported benefits, clinical data, and comparative research regarding Thymalin.

Key Clinical Benefits

Researc indicates that Thymalin primarily acts on the T-cell mediated immune response, helping to normalize the ratio and function of T-lymphocytes.

• Immune System Restoration: It enhances the production of CD28+ T-lymphocytes (mature T-cells). Studies in the context of viral infections (like COVID-19) showed that Thymalin stimulated the differentiation of hematopoietic stem cells into mature immune cells, helping to counter immune suppression.
• Geroprotective (Anti-Aging) Effects: Long-term clinical trials in Russia followed patients for over 6–10 years. Results showed a 2.0 to 2.1-fold decrease in mortality in patients over age 60 who were treated with Thymalin compared to the control group.
• Disease Prevention: Regular use has been linked to a significant reduction in the incidence of acute respiratory diseases, hypertension, osteoporosis, and ischemic heart disease.
• Synergistic Effects: When combined with Epithalamin (a pineal gland peptide), the mortality rate reduction was even more pronounced (up to 4.1-fold in some cohorts), suggesting a powerful synergy between immune and endocrine bioregulation.

Comparative Analysis: Thymalin vs. Thymosin Alpha-1

While both are thymic peptides, they are often confused. Here is how they differ in clinical reporting:

Feature	Thymalin	Thymosin Alpha-1 (T$\alpha$1)
Composition	A complex “extract” containing multiple peptide fractions.	A specific, synthetic 28-amino acid sequence.
Primary Goal	Broad bioregulation and organ-specific restoration (Longevity).	Acute immune stimulation and antiviral/antitumor activity.
Clinical Use	Age-related decline, chronic inflammation, metabolic health.	Hepatitis B/C, cancer adjuvant, severe viral infections.
Regimen	Typically cycles (e.g., 10 days, twice a year).	Often more frequent dosing during acute illness.